CAMPATH-1H reduces the risk of graft versus host disease following allogeneic hematopoietic stem cell transplantation and minimally myelosuppressive conditioning treatment with low dose total body irradiation and Cyclosporine/Mycophenotate Mofetil immunosuppression.

S Devereux, J E Parker, T Shafi, A Pagliuca, E Macdonald, G J Mufti

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)355B - 356B
Issue number11
Publication statusPublished - 2001

Cite this